步长制药 (603858.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.2x

Market Cap

CNY 16.01B

MomentumView details →

1D Return

−2.19%

YTD Return

−5.05%

RSI (14)

39.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

15.2x

Market Cap

CNY 16.01B

RSI (14)

39.7

MomentumView details →

1D Return

−2.19%

YTD Return

−5.05%

ProfitabilityView details →

Gross Margin

63.31%

Net Margin

3.20%

EBITDA Margin

9.22%

ROE (TTM)

3.66%

ROA (TTM)

1.90%

Asset Turnover

0.60x

GrowthView details →

Revenue YoY

+4.65%

EPS YoY

+208.02%

FCF YoY

−75.53%

Revenue CAGR 3Y

−7.39%

EPS CAGR 3Y

+8.83%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.29x

Current Ratio

1.22x

Quick Ratio

0.56x

Div Yield

3.84%

Div Rate

CNY 0.57

Div Growth 1Y

−53.85%

Financials snapshotView financials →

Revenue (TTM)

11.67B

Net Income (TTM)

373.94M

Op. CF (TTM)

444.32M

Latest newsMore news →

Stepun Pharmaceutical's wholly-owned subsidiary Baoding Tianhao Pharmaceutical received a drug registration certificate from China's National Medical Products Administration for terbinafine hydrochloride spray, a Class 4 chemical OTC drug for treating fungal skin infections.8d ago

Step Pharmaceutical announced its first-half 2026 results, with revenue of 5.003 billion yuan, down 11.67% year-on-year, and net profit of 503 million yuan, down 19.93% year-on-year.8d ago

Similar companies

Neurocrine Biosciences, Inc.NBIX Fujian Haixi Pharmaceuticals Co., Ltd.02637.HK 华润双鹤600062.SH 健康元600380.SH Grand Pharmaceutical Group Limited00512.HK 华润江中600750.SH Find similar companies →

Latest newsMore news →

Stepun Pharmaceutical's wholly-owned subsidiary Baoding Tianhao Pharmaceutical received a drug registration certificate from China's National Medical Products Administration for terbinafine hydrochloride spray, a Class 4 chemical OTC drug for treating fungal skin infections.8d ago Step Pharmaceutical announced its first-half 2026 results, with revenue of 5.003 billion yuan, down 11.67% year-on-year, and net profit of 503 million yuan, down 19.93% year-on-year.8d ago